Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Role of the Tear Film in Refraction: Quantitative Evaluation Before and After Rexon-Eye Therapy.

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti·2026

Same author

Clinical Results Following the Implantation of a New Toric Intraocular Lens with Extended Depth of Focus.

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti·2025

Same author

Two-year results of Preserflo Microshunt use in Open-angle Glaucoma Surgery.

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti·2025

Same author

Efficient dataset extension using generative networks for assessing degree of coating degradation around scribe.

Frontiers in artificial intelligence·2024

Same author

Serum autoantibodies against hexokinase 1 manifest secondary to diabetic macular edema onset.

Diabetes research and clinical practice·2024

Same author

Correction: Conservative management of complete fetal expulsion into the abdominal cavity after silent uterine rupture-case report.

BMC pregnancy and childbirth·2023

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions

Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions

Published on: April 28, 2026

AquaLase versus NeoSoniX--a comparison study.

Nada Jiraskova¹, Pavel Rozsival, Jana Kadlecova

¹Department of Ophthalmology, University Hospital, Hradec Kralove, Czech Republic. jirasnad@fnhk.cz

Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia

|March 18, 2008

Summary

This summary is machine-generated.

Both Infiniti AquaLase and NeoSoniX effectively remove cataracts, showing similar outcomes and minimizing intraoperative damage to ocular structures for improved visual acuity.

More Related Videos

Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses

Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses

Published on: February 23, 2024

Related Experiment Videos

Last Updated: Jul 6, 2026

Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions

Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions

Published on: April 28, 2026

Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses

Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses

Published on: February 23, 2024

Area of Science:

Ophthalmology
Surgical Technology

Background:

Cataract surgery is a common procedure to restore vision.
Newer technologies aim to improve surgical outcomes and minimize ocular tissue damage.

Purpose of the Study:

To compare the surgical metrics and outcomes of Infiniti AquaLase and NeoSoniX cataract removal modalities.

Main Methods:

A prospective study of 50 patients with bilateral cataracts.
Eyes were treated with AquaLase (right) and NeoSoniX (left).
Evaluated best corrected visual acuity (BCVA), endothelial cell density, and pachymetry pre- and postoperatively.

Main Results:

Postoperative BCVA improved in all eyes, reaching 0.8 or better by day one.
Endothelial cell density and pachymetry showed minimal changes one month post-surgery.
No significant differences were noted between AquaLase and NeoSoniX in key metrics.

Conclusions:

Both NeoSoniX and AquaLase are effective cataract removal techniques.
Both modalities demonstrate a capacity to minimize intraoperative damage to ocular structures.